MedTrace Logo

Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases

NCT01890278 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-07-01

No results posted yet for this study

Summary

In this study the patient will receive either whole brain radiation therapy given by intensity modulated radiation therapy (IMRT) or standard conventional radiation. In IMRT therapy radiation dose to the parts of the brain that do not contain tumors is reduced. This study will look to see if this approach results in less hair loss or fewer memory Problems, as compared to the standard technique. The study will also look at the effectiveness of both techniques in controlling the growth of the tumor.

Conditions

  • Metastatic Brain Cancer

Interventions

RADIATION

Whole Brain IMRT

RADIATION

Conventional Whole Brain RT

Sponsors & Collaborators

  • Good Samaritan Hospital Medical Center, New York

    lead OTHER

Principal Investigators

  • Johnny Kao, MD · Good Samaritan Hospital Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01890278 on ClinicalTrials.gov